Searched for
ZYDUS CADILA GROUP
Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...- Zydus Cadila now plans to test its Covid-19 vaccine for 5-12 age groupThe pharma major has already covered 800-plus children in 12-18 years clinical trials.
- Zydus Cadila gets USFDA nod for antidepressant drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride ...
- Zydus Cadila launches new product for COPD patients in IndiaDrug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pu...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- Zydus Cadila gets USFDA nod for orthostatic hypotension drugThe drug is used for certain patients who have symptoms of low blood pressure when standing. This condition is also known as orthostatic hy...
- Zydus Cadila gets USFDA nod for blood pressure lowering drugZydus Cadila has received the final approval from the United States Food and Drug Administration to market Chlorthalidone tablets.
- USFDA clears Zydus Cadila's generic mental disorder drugThe medication is used to treat certain mental/mood disorders.
- Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on WednesdayET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country’s fourt...
- Zydus Cadila gets USFDA nod for skin ointmentThe company has received final approval from the US Food and Drug Administration (USFDA) to market its product, Zydus Cadila said in a stat...
- Zydus Cadila launches anti-ulcer drug in USThe Gujarat-based group has more than 130 USFDA approvals and has filed over 300 abbreviated new drug applications (ANDAs) since it commenc...
- Zydus Cadila gets USFDA nod for diabetes treatment drugZydus Cadila has received final approval from the US health regulator to market Nateglinide tablets, used for treatment of diabetes.
- Warner Chilcott & Cadila Healthcare settles patent litigationIndia's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.
- Zydus Cadila Group to merge its three subsidiaries with its listed entity Cadila Healthcare LtdIn 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...
- Cadila Healthcare to merge certain subsidiaries with itselfDrug maker Cadila Healthcare today said its board has approved the merger of various wholly-owned subsidiaries, including Zydus Animal Heal...
- Zydus Cadila gets approval for Doxepin Hcl, to launch in 2020The estimated sales in 2012 as per IMS for Doxepin Hcl, which falls in the neuropsychiatry segment, was $15.5 million, as per company.
- Zydus Cadila gets US approval for anti-diabetic drug sellZydus Cadila has received the final approval from the USFDA to market anti-diabetic drug Pioglitazone HC1 tablets in the US markets.
- Zydus Hospital to start in Ahmedabad, to foray into VadodaraZydus Hospital expects to commission its Ahmedabad hospital project by the end of 2013.
- Zydus Wellness clocks 10% rise in net profitydus Wellness Ltd, a group company of Zydus Cadila, posted a 10% rise in net profit for the first quarter of the current financial year 201...
- Zydus eyes acquisitions to turn consumer arm into Rs 500-cr companyZydus Cadila Group, is looking for an exponential grown of its consumer product subsidiary, Zydus Wellness Ltd (ZWL).
Load More
